MGMT and glioblastoma: For one, glioblastoma tumors are cellularly and molecularly heterogeneous, both within and between tumors.36 To this extent, MGMT promoter methylation may vary within samples of a single lesion, different multi-focal lesions, or between reoccurrences.38 This variability may be a source of sampling bias that is unaccounted for.